Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors. (Q46036804)
Jump to navigation
Jump to search
scientific article published on 25 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors. |
scientific article published on 25 December 2012 |
Statements
1 reference
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors. (English)
1 reference
Mark C Genovese
1 reference
Roy M Fleischmann
1 reference
Maria Greenwald
1 reference
Julie Satterwhite
1 reference
Melissa Veenhuizen
1 reference
Li Xie
1 reference
Pierre-Yves Berclaz
1 reference
Stephen Myers
1 reference
Olivier Benichou
1 reference
25 December 2012
1 reference
72
1 reference
9
1 reference
1461-1468
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference